NIH-funded research R01 grant

Metabolic effects of PFAS exposure in the Cape Fear Basin (GenX Exposure Study)

Official title: Metabolic impacts of PFAS exposure in the Cape Fear Basin: GenX Exposure Study

Funded at North Carolina State University Raleigh · NIH-11541905 · Data updated 2026-11-12

This NIH grant studies how PFAS chemicals in drinking water may affect metabolism and weight-related health in adults and children living along the Cape Fear River.

More Fear research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNorth Carolina State University Raleigh
NIH-funded
Lab location1 site (Raleigh, United States)
Project startAugust 1, 2026
Project endJuly 31, 2030
Funding year2026
Award (this year)$4,233,899
NIH project number1R01ES039536-01
Project IDNIH-11541905 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants include adults and children in the three exposed NC communities who have lived in areas reliant on PFAS-contaminated water for a substantial period.

Less likely to help

Individuals with no PFAS exposure or not meeting residence duration criteria may have limited direct benefit from this study.

What this research studies

PFAS chemicals from drinking water are being studied in three NC communities to understand how exposure relates to lipid disorders and obesity. Researchers will work with local community groups to measure PFAS levels in people and assess metabolic health markers. The study aims to connect environmental exposure with real-world health impacts and inform protective actions for families. Participation may involve health questionnaires, sample collection, and community-engaged research activities.

Why it matters

Potential benefit: If successful, findings could help communities reduce PFAS exposure and guide public health interventions to prevent obesity and lipid disorders associated with these chemicals.

How similar studies have gone: Previous PFAS exposure studies have linked certain PFAS to metabolic changes, supporting the relevance of this research.

Where this research is happening

  • North Carolina State University Raleigh
    Raleigh, United States
    Active

Researchers

  • Principal investigator: Hoppin, Jane — North Carolina State University Raleigh
  • Study coordinator: Hoppin, Jane

Related research

Other NIH-funded projects on the same topics.

  • Ketamine to boost fear extinction and memory on PTSD patients

    A study testing whether ketamine can help people with PTSD better relearn and forget fear when given in a guided treatment plan.

    NIH research Yale University · New Haven, United States · NIH-11592530

  • Inflammation and fear learning in PTSD

    This study looks at how a temporary inflammatory challenge affects fear extinction in people with and without PTSD to better understand how PTSD could be treated.

    NIH research Northern California Institute/res/edu · San Francisco, United States · NIH-11468318

  • Sleep-based brain wiring of fear memory in the amygdala

    A study in people or animals will look at how sleep helps the amygdala store fear memories by using advanced brain imaging and genetic tools to understand memory changes.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11456018

  • Spatial circuits in the prefrontal cortex that control fear and discrimination

    Researchers are exploring how different parts of the prefrontal cortex help decide when to feel fear or not, with the goal of better understanding anxiety-related conditions.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11448740

  • Understanding and improving fear and safety learning in OCD

    A study at Yale will test brain-based methods to help adults with OCD improve safety learning and fear extinction during therapy.

    NIH research Yale University · New Haven, United States · NIH-11415686

  • Targeting Vasopressin and Oxytocin Receptors to Treat Anxiety and Fear

    Researchers are testing how brain chemical signals related to vasopressin and oxytocin in the BNST region affect fear and anxiety, with the goal of identifying new ways to treat anxiety disorders.

    NIH research Rosalind Franklin Univ of Medicine & Sci · North Chicago, United States · NIH-11408439

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.